PetIQ DIO Ratio 2011-2026 | PETQ

Annual DIO Ratio PetIQ

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
64.9	61.3	47.5	55.3	48.3	75.5	74.6	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
75.5	47.5	61.1

Quarterly DIO Ratio PetIQ

2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
28.6	-	88.2	78.7	55.3	-	61.4	53.7	50.4	-	68.7	39.7	52.4	-	45.8	39.2	63.4	-	78.4	58.1	62.6	-	83.7	56.4	65.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
88.2	28.6	59.5

DIO Ratio of other stocks in the Drug manufacturers industry

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Alimera Sciences ALIM	58.7	-	-	$ 142 M	USA
Adamis Pharmaceuticals Corporation ADMP	48.9	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	459	-	-	$ 754 M	USA
Canopy Growth Corporation CGC	167	$ 1.19	-	$ 128 M	Canada
AcelRx Pharmaceuticals ACRX	133	-	7.5 %	$ 6.35 M	USA
Cronos Group CRON	221	$ 2.67	-0.74 %	$ 1.42 B	Canada
Agile Therapeutics AGRX	82.7	-	10.11 %	$ 58.2 M	USA
Catalent CTLT	71.9	-	-	$ 11.5 B	USA
DURECT Corporation DRRX	460	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	149	-	-39.89 %	$ 27.7 M	USA
HEXO Corp. HEXO	703	-	2.45 %	$ 38.1 M	Canada
Endo International plc ENDP	100	-	-	$ 28.9 M	Irlanda
Evoke Pharma EVOK	995	-	-	$ 36.6 M	USA
Emergent BioSolutions EBS	176	$ 13.9	-	$ 712 M	USA
Athenex ATNX	158	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	366	$ 21.5	-	$ 2.05 B	France
Evolus EOLS	50.3	$ 5.66	-	$ 351 M	USA
Harrow Health HROW	80.1	$ 51.0	-4.67 %	$ 1.66 B	USA
China Pharma Holdings CPHI	168	$ 1.35	5.88 %	$ 23.6 M	China
Jupiter Wellness JUPW	59.7	-	-	$ 33.6 M	USA
OrganiGram Holdings OGI	2.83 K	$ 1.68	-	$ 402 M	Canada
Bausch Health Companies BHC	172	$ 7.9	3.47 %	$ 2.88 B	Canada
Pacira BioSciences PCRX	246	$ 26.0	-	$ 1.2 B	USA
Lannett Company LCI	127	-	1.15 %	$ 7.11 M	USA
Cumberland Pharmaceuticals CPIX	239	$ 5.19	-	$ 73 M	USA
Sonoma Pharmaceuticals SNOA	117	$ 3.74	-1.58 %	$ 4.64 M	USA
Organogenesis Holdings ORGO	85.9	$ 4.3	-	$ 566 M	USA
Aurora Cannabis ACB	1.35 K	$ 4.24	-	$ 86.3 M	Canada
Veru VERU	179	$ 2.37	1.72 %	$ 320 M	USA
Recro Pharma REPH	49.1	-	-4.76 %	$ 65.3 M	USA
Perrigo Company plc PRGO	143	$ 14.59	-1.19 %	$ 2 B	USA
ProPhase Labs PRPH	30.1	-	-	$ 5.07 M	USA
Rockwell Medical RMTI	28.5	$ 0.95	2.78 %	$ 22.2 M	USA
cbdMD YCBD	165	$ 1.1	-	$ 4.74 M	USA
Radius Health RDUS	204	-	-	$ 1.42 B	USA
OptiNose OPTN	370	-	-	$ 1.08 B	USA
Assertio Holdings ASRT	347	$ 9.43	-1.05 %	$ 670 M	USA
PLx Pharma PLXP	97.2	-	-27.8 %	$ 2.56 M	USA
Tilray TLRY	170	$ 8.99	-	$ 5.56 B	Canada
TherapeuticsMD TXMD	1.04 K	$ 2.04	-	$ 21.3 M	USA
Viatris VTRS	140	$ 12.46	-	$ 15.1 B	USA
Zomedica Corp. ZOM	183	-	-0.21 %	$ 98 M	USA